XOMA (XOMA) 052 Clinical Results Support Novel Anti-Inflammatory Approach to Type 2 Diabetes Treatment

June 8, 2009 7:50 AM EDT Send to a Friend
XOMA Ltd. (Nasdaq: XOMA) announced new results which included additional data for up to three months and new measures of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login